Every record from Janoshik · page 22
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043507 | GHRP-2 | BCH | BCH-2508-M6544 | 2026-Q1 | 98.34 | 5.10 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-043206 | GHRP-6 | SGN | SGN-2510-P9566 | 2026-Q1 | 98.68 | 1.32 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-042778 | Liraglutide | GGPeps | GGPE-2510-C9973 | 2026-Q1 | 99.30 | 5.04 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042231 | Semax | Homopeptide | HOMO-2512-Y1524 | 2026-Q1 | 99.93 | 7.95 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041611 | Tirzepatide | QSC | QSC-2511-N7625 | 2026-Q1 | 99.58 | 2.31 | — | Laboratory-retained | 0 | PASS |
| AX-2026-041320 | ARA-290 | WWB | WWB-2511-S3009 | 2026-Q1 | 99.42 | 5.13 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2026-043579 | Tirzepatide | BCH | BCH-2602-V8155 | 2026-Q1 | 98.81 | 6.77 | 103.9 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-043482 | BPC-157 | WXT | WXT-2602-P5658 | 2026-Q1 | 98.18 | 1.65 | 103.0 | Buyer-sourced | 2 | MARGINAL |
| AX-2026-042226 | Semax | Homopeptide | HOMO-2512-Y1524 | 2026-Q1 | 99.69 | 8.09 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041782 | TB-500 | FGP | FGP-2601-T1617 | 2026-Q1 | 99.35 | 3.86 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041592 | Retatrutide | QSC | QSC-2510-H7626 | 2026-Q1 | 97.90 | 3.29 | 92.7 | Laboratory-retained | 2 | MARGINAL |
| AX-2026-043430 | MOTS-c | WXT | WXT-2512-K4589 | 2026-Q1 | 97.64 | 1.40 | 101.6 | Supplier-supplied | 1 | FAIL |
| AX-2026-042401 | Semaglutide | SWB | SWB-2512-L5147 | 2026-Q1 | 98.55 | 5.40 | 106.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042223 | PT-141 (Bremelanotide) | Homopeptide | HOMO-2512-V9618 | 2026-Q1 | 99.32 | 4.75 | 107.5 | Supplier-supplied | 0 | PASS |
| AX-2026-042485 | Melanotan II | SWB | SWB-2602-J6019 | 2026-Q1 | 99.33 | 4.58 | 105.1 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041794 | BPC-157 | FGP | FGP-2512-A2448 | 2026-Q1 | 99.52 | 3.68 | 98.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041316 | ARA-290 | WWB | WWB-2511-S3009 | 2026-Q1 | 99.79 | 5.17 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043349 | BPC-157 | CPC | CPC-2510-R2456 | 2026-Q1 | 98.24 | 8.53 | 103.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042836 | CJC-1295 with DAC | GGPeps | GGPE-2510-T1661 | 2026-Q1 | 98.01 | 5.90 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042528 | PEG-MGF | ERP | ERP-2509-K6500 | 2026-Q1 | 98.08 | 5.50 | 89.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042446 | MGF | SWB | SWB-2601-E6319 | 2026-Q1 | 98.41 | 4.61 | 102.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042246 | Melanotan II | Homopeptide | HOMO-2511-M1199 | 2026-Q1 | 99.05 | 3.83 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042203 | Afamelanotide | Homopeptide | HOMO-2509-K9821 | 2026-Q1 | 99.59 | 4.60 | 100.0 | Supplier-supplied | 2 | FAIL |
| AX-2026-042003 | Epitalon | TFC | TFC-2508-W5644 | 2026-Q1 | 98.50 | 6.39 | — | Buyer-sourced | 0 | FAIL |
| AX-2026-041963 | KPV | TFC | TFC-2508-M4888 | 2026-Q1 | 99.85 | 2.98 | — | Supplier-supplied | 0 | FAIL |
| AX-2026-041640 | Selank | QSC | QSC-2601-N8430 | 2026-Q1 | 99.93 | 6.96 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041491 | TB-500 | QYB | QYB-2512-R5934 | 2026-Q1 | 99.93 | 5.11 | 89.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043508 | GHRP-2 | BCH | BCH-2508-M6544 | 2026-Q1 | 98.57 | 5.13 | 107.0 | Supplier-supplied | 1 | FAIL |
| AX-2026-043428 | CJC-1295 (no DAC) | WXT | WXT-2601-P4636 | 2026-Q1 | 98.15 | 6.38 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042130 | Semax | Homopeptide | HOMO-2602-S8315 | 2026-Q1 | 99.56 | 9.36 | 103.4 | Laboratory-retained | 2 | MARGINAL |
| AX-2026-042128 | Semax | Homopeptide | HOMO-2602-S8315 | 2026-Q1 | 99.93 | 9.16 | 105.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041633 | Semaglutide | QSC | QSC-2602-G8557 | 2026-Q1 | 98.79 | 4.99 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041244 | Retatrutide | WWB | WWB-2510-H1662 | 2026-Q1 | 99.24 | 4.83 | 89.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043233 | N-Acetyl Semax Amide | SGN | SGN-2508-K1228 | 2026-Q1 | 99.68 | 8.16 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042878 | MK-677 (Ibutamoren mesylate) | GGPeps | GGPE-2509-T2530 | 2026-Q1 | 98.98 | 3.99 | — | Laboratory-retained | 1 | FAIL |
| AX-2026-042768 | Ipamorelin | GGPeps | GGPE-2508-E9990 | 2026-Q1 | 99.53 | 5.23 | 95.9 | Buyer-sourced | 0 | PASS |
| AX-2026-041997 | Semaglutide | TFC | TFC-2508-A5297 | 2026-Q1 | 98.44 | 4.33 | 105.9 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041575 | CJC-1295 with DAC | QSC | QSC-2512-G6894 | 2026-Q1 | 98.14 | 2.73 | 95.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043303 | L-Glutathione (reduced) | CPC | CPC-2602-D2535 | 2026-Q1 | 98.68 | 7.52 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042132 | Semax | Homopeptide | HOMO-2602-S8315 | 2026-Q1 | 99.93 | 9.37 | 106.8 | Supplier-supplied | 3 | MARGINAL |